COMPARATIVE BIOAVAILABILITY OF A SUSTAINED-RELEASE PREPARATION OF AMITRIPTYLINE AND CONVENTIONAL TABLETS

被引:16
作者
JORGENSEN, A [1 ]
机构
[1] H LUNDBECK & CO AS,DEPT BIOCHEM,DK-2500 COPENHAGEN,DENMARK
关键词
D O I
10.1007/BF00609858
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:187 / 190
页数:4
相关论文
共 8 条
[1]  
Brasseur R, 1975, Acta Psychiatr Belg, V75, P182
[2]  
DOST FH, 1968, GRUNDLAGEN PHARMAKOK, P267
[3]  
GIBALDI M, 1975, PHARMACOKINETICS, P145
[5]   PHARMACOKINETICS OF AMITRIPTYLINE INFUSED INTRAVENOUSLY IN MAN [J].
JORGENSEN, A ;
HANSEN, V .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (05) :337-341
[6]  
JORGENSEN A, 1975, ACTA PHARMACOL TOX, V36, P79
[7]   BIOLOGICAL HALF-LIFE OF AMITRIPTYLINE [J].
JORGENSEN, A ;
STAEHR, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (01) :62-64
[8]   TRIAL OF A SUSTAINED-RELEASE FORM OF AMITRIPTYLINE (LENTIZOL) IN TREATMENT OF DEPRESSIVE ILLNESS [J].
SEDMAN, G .
BRITISH JOURNAL OF PSYCHIATRY, 1973, 123 (572) :69-71